论文部分内容阅读
作者采用随机、双盲、平行、安慰剂对照研究,评价了房颤或房补病人静注硫氮(艹卓)酮有效后继之24小时持续静滴的安全性和效果。患者年龄>18岁,并已确诊有发作持续24小时以上的房颤或房扑。不包括有下列情况的病人:心功能Ⅲ或Ⅳ级、窦房结功能不良、Ⅱ和Ⅲ度房室传导阻滞、预激综合征、收缩压低于
In a randomized, double-blind, parallel, placebo-controlled study, the authors evaluated the safety and efficacy of continuous intravenous infusion of intravenous infusion of azathia following atrial fibrillation or atrial fibrillation for 24 hours. Patients were> 18 years old and had been diagnosed with atrial fibrillation or atrial flutter for more than 24 hours. Does not include patients with the following conditions: cardiac function Ⅲ or Ⅳ level, sinus node dysfunction, Ⅱ and Ⅲ degree atrioventricular block, pre-excitation syndrome, systolic blood pressure less than